Douglas Baumstein

Doug is a first-chair litigator with significant experience representing clients in securities, corporate governance, complex commercial, and bankruptcy-related litigation. He has a strong track record of achieving favorable outcomes for clients before federal and state courts across the United States, including New York, Delaware, Maryland, Nevada, Texas, New Jersey, and Massachusetts.

Doug has successfully represented numerous high-profile clients in securities law cases. Recently he obtained dismissal in full of securities law claims against ReWalk Robotics, a medical device company, and Aixtron SE, the German technology company. He also argued successfully in the Southern District of New York, and on appeal before the Second Circuit Court of Appeals, for a dismissal of all securities law claims against Dynegy officers and directors arising out of actions they took to restructure that energy company. Doug also led the representation of Aracruz (now Fibria Celulose) in its successful resolution of claims arising out of losses it suffered in connection with its purchases of foreign exchange derivatives. Continuing his work in the life sciences industry, Doug has considerable experience representing clients in both the branded and non-branded space.